Mumbai, 26 Feb 2024: Ahmedabad-headquartered Zydus Lifesciences has received the World Health Organisation’s (WHO’s) prequalification approval for the active pharmaceutical ingredient (API) called Miltefosine, to treat Leishmaniasis or Kala Azar, the company said.
View Details

Related News

• UT man duped of Rs 1.4 lakh in fake Patanjali treatment scam (13-01-2025)

---

• Kidney, liver damage in 3 new moms given faulty drip (13-01-2025)

---

• WB govt bans 10 intravenous fluids in hospitals for patient safety (13-01-2025)

---

• 15 lakh annual surgical site infections in India:ICMR study (13-01-2025)

---

• NCB and police seized Narcotic capsules in Hindaun City, one arrested (12-01-2025)

---

• Assam: Massive consignment of illicit cough syrup seized in Guwahati (12-01-2025)

---

• Police probe company behind tramadol diversion in Punjab (12-01-2025)

---

• ACB caught UP Pharmacy Council contract worker red-handed accepting bribe of Rs 5,000 (12-01-2025)

---

• Medical shop running without license, medicines worth 50 thousand seized (12-01-2025)

---

• Drug business under the guise of medicine shop: 600 injections seized (12-01-2025)

---